Bayer AG's stock demonstrated modest trading activity on Friday, settling at €21.80 with a marginal decline of 0.3%. Trading within a narrow corridor, the stock fluctuated between €21.76 and €21.94, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.

Bayer AG's stock exhibited a cautiously positive trend in Wednesday's trading, navigating within a narrow range of €21.28 to €21.77 on XETRA. The trading volume remained substantial with over 2.4 ...

The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into Bayer AG's tech activities, including its digital ...

Bayer pleaded with Missouri lawmakers Thursday to pass legislation critics say would shield the company from lawsuits claiming its glyphosate-based herbicide Roundup causes cancer.

The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

Dhanuka Agritech has acquired international rights for two fungicides from Bayer AG for Rs 165 crore. The acquisition includes rights to Bayer's Melody brand, its sub-brands for Iprovalicarb, and ...

Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...

Bayer has signed a new exclusive distribution agreement with UK-based Ecospray to market a biological liquid nematicide sourced from garlic.